Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pacira Pharm Inc (PCRX)

Pacira Pharm Inc (PCRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Pacira's (PCRX) Q4 Earnings Top Estimates, Revenues In Line

Pacira (PCRX) beats earnings estimates in the fourth quarter of 2019. Revenues are in line with estimates.

UTHR : 112.86 (-2.16%)
PCRX : 46.28 (-1.91%)
NOVN : 0.46 (-12.32%)
KALV : 13.35 (+0.45%)
After Yesterday's Decline of 2.35%, Pacira Pharmaceu Offers Investors Better Value

Pacira Pharmaceu (NASDAQ:PCRX) traded in a range yesterday that spanned from a low of $47.32 to a high of $51.30. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of...

PCRX : 46.28 (-1.91%)
Bausch's (BHC) Q4 Earnings Match Estimates, Revenues Miss

Bausch (BHC) reports mixed fourth-quarter results, with earnings meeting expectations but sales missing the same.

UTHR : 112.86 (-2.16%)
PCRX : 46.28 (-1.91%)
XNCR : 32.09 (-3.69%)
BHC : 24.77 (-4.73%)
Pacira: 4Q Earnings Snapshot

PARSIPPANY, N.J. (AP) _ Pacira Pharmaceuticals Inc. (PCRX) on Thursday reported a fourth-quarter loss of $4.9 million, after reporting a profit in the same period a year earlier.

PCRX : 46.28 (-1.91%)
Pacira Reports Record Fourth Quarter and Full-Year Revenues

-- Full-year 2019 revenue increases 25 percent to $421 million versus 2018 --

PCRX : 46.28 (-1.91%)
3 Top-Ranked Stocks Poised for an Earnings Beat

Count on these top-ranked stocks that are likely to beat earnings estimates in their next releases.

PCRX : 46.28 (-1.91%)
FTNT : 105.05 (-3.36%)
MITK : 9.22 (-2.74%)
Zoetis' (ZTS) Earnings and Revenues Beat Estimates in Q4

Zoetis (ZTS) beats on both earnings and sales in the fourth quarter of 2019.

ZTS : 134.82 (-2.58%)
PCRX : 46.28 (-1.91%)
FGEN : 42.96 (-1.45%)
KALV : 13.35 (+0.45%)
Pacira to Report 2019 Financial Results on Thursday February 20, 2020

Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its fourth quarter and year ended December 31, 2019 financial results before the open of the U.S. markets on Thursday, February...

PCRX : 46.28 (-1.91%)
FibroGen's (FGEN) NDA for Roxadustat Accepted by the FDA

The FDA accepts FibroGen's (FGEN) NDA for roxadustat for the treatment of anemia of chronic kidney disease in both non-dialysis-dependent and dialysis-dependent patients.

AZN : 47.08 (-1.07%)
PCRX : 46.28 (-1.91%)
FGEN : 42.96 (-1.45%)
KALV : 13.35 (+0.45%)
Intra-Cellular T has the Best Relative Performance in the Pharmaceuticals Industry (ITCI , PCRX , ZGNX , NKTR , ZTS )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

ITCI : 23.02 (+0.09%)
PCRX : 46.28 (-1.91%)
ZGNX : 28.00 (-3.08%)
Will Pacira BioSciences Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor in Pacira BioSciences.

PCRX : 46.28 (-1.91%)
Interesting PCRX Put And Call Options For March 20th

Investors in Pacira BioSciences Inc saw new options become available this week, for the March 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PCRX options...

PCRX : 46.28 (-1.91%)
The Zacks Analyst Blog Highlights: Meritage Homes, Cable One, GoDaddy, Pacira and Great Lakes Dredge

The Zacks Analyst Blog Highlights: Meritage Homes, Cable One, GoDaddy, Pacira and Great Lakes Dredge

GDDY : 72.51 (-3.41%)
GLDD : 10.06 (-2.75%)
MTH : 68.83 (-4.02%)
CABO : 1,665.00 (-5.12%)
PCRX : 46.28 (-1.91%)
Prestige Brands has the Best Relative Performance in the Pharmaceuticals Industry (PBH , RVNC , PCRX , BMY , MNK )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

PCRX : 46.28 (-1.91%)
PBH : 39.61 (-2.82%)
RVNC : 24.76 (-7.99%)
The Zacks Analyst Blog Highlights: GoDaddy, Great Lakes Dredge, LPL and Pacira BioSciences

The Zacks Analyst Blog Highlights: GoDaddy, Great Lakes Dredge, LPL and Pacira BioSciences

GDDY : 72.51 (-3.41%)
GLDD : 10.06 (-2.75%)
LPLA : 84.48 (-3.53%)
PCRX : 46.28 (-1.91%)
5 Big Winners From Trump's State of the Union Address

Trump touted stock market's record run in the State of the Union speech, and painted a rosy picture of the economy. Given the positives, investing in growth stocks won't be a bad proposition.

GDDY : 72.51 (-3.41%)
GLDD : 10.06 (-2.75%)
MTH : 68.83 (-4.02%)
CABO : 1,665.00 (-5.12%)
PCRX : 46.28 (-1.91%)
4 Top Growth Stocks to Buy as Coronavirus Fears Subside

The People's Bank of China offered funds in the overnight market to the tune of $71 billion for the second successive day to alleviate the economic stress of containing the viral outbreak.

GDDY : 72.51 (-3.41%)
GLDD : 10.06 (-2.75%)
LPLA : 84.48 (-3.53%)
PCRX : 46.28 (-1.91%)
Pacira BioSciences Sees Hammer Chart Pattern: Time to Buy?

Pacira BioSciences has been struggling lately, but the selling pressure may be coming to an end soon.

PCRX : 46.28 (-1.91%)
Heron Therapeutics (HRTX) Catches Eye: Stock Jumps 6.8%

Heron Therapeutics (HRTX) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

PCRX : 46.28 (-1.91%)
HRTX : 19.14 (-8.55%)
New Strong Buy Stocks for January 21st

New Strong Buy Stocks for January 21st

WRB : 75.17 (-2.43%)
PCRX : 46.28 (-1.91%)
MUR : 19.91 (-5.42%)
CURO : 10.49 (-13.02%)
AER : 54.54 (-5.95%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS -1.74 , SEDG -2.63 , THC -3.44 , TER -2.25 , LITE -2.20
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar